Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken Chairman & Managing Director of Sun Pharma has turned the company from a ...

who is Dilip Shanghvi’s son. Some analysts see Sun Pharma’s growth to be driven by a mix of specialty, ROW and India markets. “We see the company delivering 8-10 per cent revenue growth on a ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug launch.

According to market estimates, Leqselvi is projected to contribute $90 million to Sun Pharma's sales in FY26, and $125 million in FY27 ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug launch. Checkpoint is a commercial-stage company that develops novel ...

Sun Pharma chairman and managing director Dilip Shanghvi said: "Combining Unloxcyt…with Sun Pharma's global presence means patients with cSCC may soon have access to an important, new treatment ...

“Over the years, with Sun Pharma’s strategic interventions, Taro has remained a key player in the generic dermatology market in a challenging environment,” said Dilip Shanghvi, the Indian ...

Delhi: In a major relief to Sun Pharmaceutical Industries Ltd, the U.S. Court of Appeals for the Federal Circuit has vacated ...

4.5 lakh crore. She’s also known as the daughter-in-law of Dilip Shanghvi, the founder and managing director of Sun Pharma, who is India’s wealthiest figure in the healthcare industry.

This father-son duo’s pharma company is taking on the likes of Sun Pharma, Abbot Bhavya Kaushal 15 inspiring quotes by Dilip Shanghvi, the man who built India's most valuable pharma company ...